Breast cancer research stamp extended through 2037
In committeeH.R. 8358Latest action
Sponsor: Beth Van Duyne · Representative · TX
AIDecoded by AI · checked against the recordRead the official text
Official title: Breast Cancer Research Stamp Reauthorization Act of 2026
119th Congress
Topics: Health care
Introduced:
Read the official bill on Congress.govIn plain words
The plain-language version comes first. The official text is always the reference.
HR 8358 extends the breast cancer research postage stamp program for ten more years, moving its end date from 2027 to 2037.
30-second read · 4 questions answered below
What does this do?
This bill renews a special U.S. Postal Service stamp that raises money for breast cancer research. The stamp is sold at a higher price than regular postage, and the extra amount goes toward that research. The bill moves the program's expiration date from 2027 to 2037.
Who does it affect?
Anyone who buys and uses this stamp contributes to breast cancer research funding through their regular postage purchases.
Why does it matter?
Without this extension, the program would end in 2027. Passing the bill allows the stamp to keep being sold for an additional ten years.
AI-drafted summary. Check it against the official text before you act on it.
Read the official bill on Congress.govMake the call
Where does it stand?
- IntroducedApr 16, 2026
- House committeeYou are here · Apr 16, 2026
- House vote
- Senate
- The president's desk
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the president.
Latest action: — Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.